High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Ozempic is a brand-name medication that’s not currently available in generic form ... Each Ozempic pen holds several doses of the drug. Your doctor or pharmacist will explain when you need ...

In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

Novo said Teva could launch its generic earlier, but not before March of 2023, unless the Victoza patents are no longer in force or there is another generic on the market.

Victoza is one of the first GLP-1 drugs — the class of wildly popular diabetes and obesity treatments that includes Ozempic ...

Eli Lilly and Novo Nordisk enjoy the highest values in the pharma sector, as investors expect years of high-volume, ...

Liraglutide results in greater reduction in BMI than placebo plus lifestyle intervention for children with obesity ...

In a phase 3 clinical trial, liraglutide was shown to reduce the body mass index in children ages 6 to 11 with obesity, according to a study published Sept. 10 in The New England Journal of Medicine.

The Medicines Patent Pool (MPP) and Novartis have unveiled a new voluntary licensing agreement to allow generic drugmakers in seven middle income nations to develop, manufacture, and supply ...

Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Liraglutide (Saxenda) added to lifestyle intervention helped reduce BMI in young children with obesity, the phase IIIa ...

Weight reduction at 1 year linked to medication active agent, dosage, treatment indication, persistence of coverage. (HealthDay News) — For patients with obesity receiving semaglutide or ...